Physician profile
Christopher R Longnecker
NPI 1255334777
$28,692.89
in general payments reported to CMS, 2019-2025
16 companies · $9,561 in 2025
The $9,561 reported for 2025 was more than what 94% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $9,520 · 2020: $3,371 · 2022: $3,001 · 2023: $2,531 · 2024: $709 · 2025: $9,561.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $7,430 · Travel and Lodging: $3,556 · Food and Beverage: $1,753 · Education: $62.01.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $7,430.00 |
| Travel and Lodging | $3,556.47 |
| Food and Beverage | $1,752.72 |
| Education | $62.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gilead Sciences, INC. | $9,133.84 | 2025 | Biktarvy |
| Biogen, INC. | $4,550.00 | 2019 | |
| Boston Scientific Corporation | $3,576.96 | 2020-2025 | Lux-Dx Insertable Cardiac Monitor, Watchman Flx, Watchman Access System |
| Medtronic, INC. | $2,709.10 | 2022-2024 | Corevalve Evolut R, Micra |
| E.R. Squibb & Sons, L.L.C. | $2,650.00 | 2019 | |
| Medtronic Vascular, INC. | $2,234.07 | 2019 | |
| Edwards Lifesciences Corporation | $1,717.39 | 2020-2024 | Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Abbott Laboratories | $1,337.10 | 2023-2025 | Mitraclip, Cardiomems, Ensite |
| Abiomed | $262.92 | 2019-2025 | Impella |
| Shockwave Medical, INC | $261.14 | 2022-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $133.93 | 2019-2025 | Lifevest |
| Chiesi USA, INC. | $62.01 | 2024 | Kengreal |
| Astrazeneca Pharmaceuticals LP | $18.21 | 2025 | |
| Philips North America LLC | $17.95 | 2025 | Azurion 7 M20 |
| Daiichi Sankyo INC. | $14.71 | 2024 | Injectafer |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kestra Medical Technology Services, INC. | $13.56 | 2025 | Assure Wcd |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Longnecker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.